Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 6—June 2024
Dispatch

Encephalitozoon cuniculi Microsporidia in Cerebrospinal Fluid from Immunocompetent Patients, Czech Republic

Author affiliations: Biology Centre of the Czech Academy of Sciences, České Budějovice, Czech Republic (B. Sak, N. Holubová, J. Fenclová, M. Kváč); University of South Bohemia, České Budějovice (K. Mansfeldová, J. Fenclová, M. Kváč); Bulovka Hospital, Prague, Czech Republic (K. Brdíčková, P. Gottliebová, E. Nyčová); Wroclaw Medical University, Wroclaw, Poland (M. Kicia, Ż. Zajączkowska)

Cite This Article

Abstract

We retrospectively analyzed of 211 frozen cerebrospinal fluid samples from immunocompetent persons in the Czech Republic and detected 6 Encephalitozoon cuniculi–positive samples. Microsporidiosis is generally underestimated and patients are not usually tested for microsporidia, but latent infection in immunodeficient and immunocompetent patients can cause serious complications if not detected and treated.

Microsporidia are obligate intracellular parasites of invertebrate and vertebrate hosts and are considered to be a sister group to fungi (1). Of the 1,300 species in >200 genera that have been described (2), Encephalitozoon cuniculi, especially genotypes I and II, is the most common in humans (3,4).

Although the digestive tract represents a port of entry, Encephalitozoon infections can occur in almost every organ system and can cause various diseases (4). Encephalitozoonosis is a serious problem in immunodeficient hosts, including HIV-positive patients and patients on immunosuppressive treatments. In immunocompetent persons, microsporidial infections are predominantly chronic and asymptomatic (5).

Recent studies have described engagement of macrophages, or other immune cells involved in the development of inflammation, serving as vehicles and transporting microsporidia toward target tissues outside the intestines (6,7). Microsporidia are often overlooked in clinical samples because diagnosis is problematic, but hidden infections can cause tremendous multisystem damage and various nonspecific pathologies, and few effective treatments are available (8). We evaluated the incidence of generally neglected Encephalitozoon spp. in immunocompetent patients by retrospectively analyzing previously collected cerebrospinal fluid (CSF) samples.

The Study

Bulovka Hospital, Prague, Czech Republic, provided 211 CSF samples that had been deep frozen at −80°C. CSF samples were collected from immunocompetent patients; the only other patient data reported were the year of birth and sex. We obtained total DNA from sediments obtained from thawed CSF together with extraction negative control in each series, as previously described (6). We used the same methods to isolate control DNA from purified E. intestinalis spores. The study was conducted beyond the routine screening of existing unused specimens and focused on potential detection of microsporidia in CSF recovered from immunocompetent patients hospitalized at 1 hospital. Because the study was performed using anonymized samples with no intervention tract, patient consent was not required.

We used an Encephalitozoon spp.specific nested PCR to amplify the internal transcribed spacer region (9,10). We included DNA of E. intestinalis microsporidia as a PCR-positive control and ultrapure water as a negative control and evaluated PCR products by gel electrophoresis.

We quantified DNA from PCR-positive samples by using reverse transcription PCR to amplify a 268-bp region of the 16S rRNA gene of E. cuniculi (10). Each run included unspiked specimens and diluent blanks. We considered results positive when the fluorescence signal crossed the baseline at <43 cycles. We used a standard curve to calculate the total number of spores in 1 mL of each sample.

We used the QIAquick Gel Extraction Kit (QIAGEN, https://www.qiagen.com) to purify PCR amplicons of the internal transcribed spacer region and submitted amplicons to SEQme (https://www.seqme.eu) for sequencing in both directions. We manually edited nucleotide sequences by using the ChromasPro 2.1.4 program (Technelysium, https://technelysium.com.au) and used MAFFT version 7 (http://mafft.cbrc.jp) to align sequences with reference GenBank submissions. We also microscopically examined PCR-positive samples. We air dried a drop of CSF, fixed it with methanol, and stained with standard Calcofluor M2R (Sigma-Aldrich, https://www.sigmaaldrich.com) (11).

Of 211 CSF samples examined, 115 were from male patients and 96 from female patients. The median patient age was 34.0 (range 2–81) years (Table). Among all samples, 6 were positive for microsporidia DNA, 0.9% (1/115) of samples from male and 5.2% (5/96) of samples from female patients. The age of positive patients ranged from 13 to 75 years (median 45.5 years). The spore concentration in samples was 30–500 spores/mL.

Figure 1

Phylogenetic analysis of Encephalitozoon cuniculi genotypes recovered from cerebrospinal fluid of immunocompetent patients, Czech Republic. Bold indicates sequences obtained in this study, identified by patient number. Sequences for comparisons were obtained from GenBank; accession numbers are in brackets. Tree was constructed by using the maximum-likelihood method. Partial sequences of 16S rRNA gene, the entire internal transcribed spacer region, and a partial sequence of 5.8S rRNA gene were inferred by using neighbor-joining analyses, and relationships were computed by using the Tamura 3-parameter method with gamma distribution and parametric bootstrap analysis of 1,000 replicates in MEGA X software (MEGA, https://www.megasoftware.net). Scale bar indicates nucleotide substitutions per site.

Figure 1. Phylogenetic analysis of Encephalitozoon cuniculigenotypes recovered from cerebrospinal fluid of immunocompetent patients, Czech Republic. Bold indicates sequences obtained in this study, identified by patient number. Sequences for comparisons...

Figure 2

Microscopic examination Encephalitozoon cuniculi­–positive cerebrospinal fluid from immunocompetent patients, Czech Republic. Microsporidial spores (arrows) were stained with Calcofluor M2R and viewed in 490 nm. A) Patient no. 139; B) patient no. 185. Scale bar indicates 10 µm.

Figure 2. Microscopic examination Encephalitozoon cuniculi­–positive cerebrospinal fluid from immunocompetent patients, Czech Republic. Microsporidial spores (arrows) were stained with Calcofluor M2R and viewed in 490 nm. A) Patient no. 139;...

Sequence analyses revealed 100% identity to E. cuniculi genotype II (GenBank accession no. MF062430) in all positive samples (Table; Figure 1). Microscopic analysis of Calcofluor M2R–stained smears confirmed the presence of spores (1–2 spores per slide) in samples obtained from 2 patients, nos. 139 and 185, who had the highest Encephalitozoon DNA burden (Figure 2). The other 4 patients were microscopically negative.

Conclusions

Although microsporidiosis is mainly detected in immunodeficient patients, data from the literature imply that otherwise healthy persons also are at risk (12,13). Those data indicate that apparently healthy persons could be infected without any clinical signs, and the risk increases with age (12). Whether microsporidial infection potentially leads to a deterioration in health that could be life-threatening in the event of a decline in immunity has not been determined (12,14,15).

The fecal–oral route is generally accepted as the most common transmission route because the spores are passed in the urine or feces of infected patients, then mostly contaminate water sources. Moreover, possible foodborne transmission, including through fresh vegetables and fruits, milk, cheese, and fermented meat products, has been reported (13). Besides those transmission routes, respiratory tract infection suggests airborne transmission by contaminated aerosols (13).

Microsporidia are small intracellular fungi capable of causing widespread infections within a few days, despite their lack of active motility and limited spreading possibilities (14). The exact spreading mechanism is still unknown; however, the possible connection between activation of proinflammatory cellular immune response and targeted transport of microsporidia toward inflammation site has been proposed on the basis of clinical and experimental data (6,7,11).

In this study, we detected microsporidia DNA in 3% of tested CSF samples from 211 patients of one hospital. The molecular data were supported by microscopy in 2 patients who had the highest spore loads. Although the other 4 PCR-positive patients tested microscopically negative, those results could be caused by limited sensitivity of microscopy in low burden samples, rather than laboratory contamination. Because we obtained uniform results from specific patients using both PCR and quantitative PCR, contamination is unlikely. Moreover, we can exclude laboratory contamination because the same trained personnel took the samples and ran PCRs under sterile conditions. In addition, PCR diagnostic laboratory is structurally divided into separate areas that adhere to the 1-direction workflow, and all negative controls used in sample processing were negative.

Our results for microsporidia detection indicate an increasing prevalence of latent microsporidiosis with patient age, which is consistent with the results of previous studies (12). Moreover, the presence of microsporidia in CSF represents a potentially serious condition; unfortunately, we cannot infer any association with the clinical condition of the patients because we did not have patient histories or reasons for collecting CSF samples. However, we can assume a possible link between the patients’ health issues and the presence of microsporidia in CSF, similar to those found in another study (15). That study reported a case of a paralyzed patient with a right frontal lobe abscess containing E. cuniculi genotype I; the patient was successfully treated following appropriate treatment regimen.

In conclusion, disseminated latent microsporidiosis can cause several serious diseases with nonspecific symptoms and ambiguous etiology that can be life-threating or fatal if misdiagnosed and left untreated. We encourage increased awareness of latent microsporidiosis and development of targeted screening that enables timely treatment.

Dr. Sak is a research scientist at Biology Centre CAS, České Budějovice, Czech Republic. His research interests include detection of parasites, such as microsporidia, including diagnostics, isolation, in vitro cultivation, experimental infections, and morphological and molecular characterization.

Top

Acknowledgment

This work was supported by grants from the Grant Agency of the Czech Republic (nos. 20-10706S, 23-06571S) and National Science Centre, Poland (no. 2020/39/O/NZ6/02313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Top

References

  1. Keeling  PJ, Doolittle  WF. Alpha-tubulin from early-diverging eukaryotic lineages and the evolution of the tubulin family. Mol Biol Evol. 1996;13:1297305. DOIPubMedGoogle Scholar
  2. Cali  A, Becnel  JJ, Takvorian  PM. Microsporidia. In: Archibald JM, Simpson AGB, Slamovits CH, editors. Handbook of the protists. Cham (Switzerland): Springer; 2017. p. 1559–618.
  3. Didier  ES. Microsporidiosis: an emerging and opportunistic infection in humans and animals. Acta Trop. 2005;94:6176. DOIPubMedGoogle Scholar
  4. Didier  ES, Weiss  LM. Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis. 2011;24:4905. DOIPubMedGoogle Scholar
  5. Weber  R, Bryan  RT, Schwartz  DA, Owen  RL. Human microsporidial infections. Clin Microbiol Rev. 1994;7:42661. DOIPubMedGoogle Scholar
  6. Brdíčková  K, Sak  B, Holubová  N, Květoňová  D, Hlásková  L, Kicia  M, et al. Encephalitozoon cuniculi genotype II concentrates in inflammation foci. J Inflamm Res. 2020;13:58393. DOIPubMedGoogle Scholar
  7. Sak  B, Holubová  N, Květoňová  D, Hlásková  L, Tinavská  J, Kicia  M, et al. Comparison of the concentration of Encephalitozoon cuniculi genotypes I and III in inflammatory foci under experimental conditions. J Inflamm Res. 2022;15:272130. DOIPubMedGoogle Scholar
  8. Lallo  MA, da Costa  LF, de Castro  JM. Effect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed mice. Antimicrob Agents Chemother. 2013;57:306771. DOIPubMedGoogle Scholar
  9. Katzwinkel-Wladarsch  S, Lieb  M, Helse  W, Löscher  T, Rinder  H. Direct amplification and species determination of microsporidian DNA from stool specimens. Trop Med Int Health. 1996;1:3738. DOIPubMedGoogle Scholar
  10. Wolk  DM, Schneider  SK, Wengenack  NL, Sloan  LM, Rosenblatt  JE. Real-time PCR method for detection of Encephalitozoon intestinalis from stool specimens. J Clin Microbiol. 2002;40:39228. DOIPubMedGoogle Scholar
  11. Kicia  M, Wesolowska  M, Kopacz  Z, Kvác  M, Sak  B, Sokulska  M, et al. Disseminated infection of Encephalitozoon cuniculi associated with osteolysis of hip periprosthetic tissue. Clin Infect Dis. 2018;67:122834. DOIPubMedGoogle Scholar
  12. Sak  B, Kváč  M, Kučerová  Z, Květoňová  D, Saková  K. Latent microsporidial infection in immunocompetent individuals - a longitudinal study. PLoS Negl Trop Dis. 2011;5:e1162. DOIPubMedGoogle Scholar
  13. Sak  B, Kváč  M. Chronic infections in mammals due to microsporidia. In: Weiss LM, Reinke AW, editors. Microsporidia: current advances in biology. Cham (Switzerland): Springer Experientia Supplementum; 2022. p. 319–71.
  14. Kotková  M, Sak  B, Květoňová  D, Kváč  M. Latent microsporidiosis caused by Encephalitozoon cuniculi in immunocompetent hosts: a murine model demonstrating the ineffectiveness of the immune system and treatment with albendazole. PLoS One. 2013;8:e60941. DOIPubMedGoogle Scholar
  15. Ditrich  O, Chrdle  A, Sak  B, Chmelík  V, Kubále  J, Dyková  I, et al. Encephalitozoon cuniculi genotype I as a causative agent of brain abscess in an immunocompetent patient. J Clin Microbiol. 2011;49:276971. DOIPubMedGoogle Scholar

Top

Figures
Table

Top

Cite This Article

DOI: 10.3201/eid3006.231585

Original Publication Date: May 14, 2024

Table of Contents – Volume 30, Number 6—June 2024

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Bohumil Sak, Institute of Parasitology, Biology Centre of the Czech Academy of Sciences, Branišovská 31, 37005 České Budějovice, Czech Republic

Send To

10000 character(s) remaining.

Top

Page created: April 19, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external